|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1993-5-18
|
|
pubmed:abstractText |
Our purpose was to assess the proficiency with which cytometrically determined deoxyribonucleic acid variables from pretreatment curettage specimens identify patients at high risk for extrauterine disease or posttreatment relapse.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
168
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1206-13; discussion 1213-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8475967-Adult,
pubmed-meshheading:8475967-Aged,
pubmed-meshheading:8475967-Aged, 80 and over,
pubmed-meshheading:8475967-Curettage,
pubmed-meshheading:8475967-DNA, Neoplasm,
pubmed-meshheading:8475967-Female,
pubmed-meshheading:8475967-Humans,
pubmed-meshheading:8475967-Middle Aged,
pubmed-meshheading:8475967-Mitotic Index,
pubmed-meshheading:8475967-Neoplasm Recurrence, Local,
pubmed-meshheading:8475967-Neoplasm Staging,
pubmed-meshheading:8475967-Ploidies,
pubmed-meshheading:8475967-Prognosis,
pubmed-meshheading:8475967-Risk Factors,
pubmed-meshheading:8475967-S Phase,
pubmed-meshheading:8475967-Survival Analysis,
pubmed-meshheading:8475967-Uterine Neoplasms
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905.
|
|
pubmed:publicationType |
Journal Article
|
